Tuesday, 02 January 2024 12:17 GMT

NEURONES: Organic Growth Up 5.1% In 3Rd Quarter 2025


(MENAFN- GlobeNewsWire - Nasdaq) PRESS INFORMATION
Heading: 3rd quarter 2025 revenues Nanterre, November 5, 2025 (after trading)

Organic growth up 5.1% in 3 rd quarter 2025

(not audited, in millions of euros) 2024 2025 growth of which organic
3rd quarter revenues 196.7 207.9 + 5.7% + 5.1%
Total as at the end-September 599.1 632.2 + 5.5% + 4.7%

Achievements

In a declining French market, NEURONES has continued its momentum in the third quarter, in line with the start of the year.

Growth is particularly strong in the areas of Data & AI, digital projects, ITSM (Service Now) assignments and Business Process Management.

Turnover remained at a low level.

At 9.6% of revenues, the operating margin for the third quarter was up compared to the first half of the year. For the first nine months, it stood at 8.4%*.

Outlook

Given the improvement seen in the 3rd quarter, the group is now targeting annual revenues in excess of €850 million and operating profit of at least 8% for the full year.

* unaudited and after inclusion of 0.9% expenses related to bonus shares.

About NEURONES
With 7,300 experts, and ranking among the French leaders in consulting and digital services, NEURONES helps large companies and organizations implement their digital projects, transform their IT infrastructures and adopt new uses.

Euronext Paris (compartment A - NRO) – Euronext Tech Leaders – DSS – PEA-PME eligible

Press Relations:
O'Connection
Julia Philippe-Brutin
Tel.: +33 (0)6 03 63 06 03
...

NEURONES
Matthieu Vautier
Tel.: +33 (0)1 41 37 41 37
...
Investor Relations:
NEURONES
Paul-César Bonnel
Tel.: +33 (0)1 41 37 41 37
...

Attachment

  • neurones-third-quarter-2025-revenues

MENAFN05112025004107003653ID1110300301



GlobeNewsWire - Nasdaq

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Search